Manufacturing

Articles

Horiba has joined a consortium aimed at accelerating the development of process analytical technologies for cell and gene therapy manufacturing

Horiba Joins CGT Catapult Consortium to Accelerate Development of PAT

Yposkesi is building its second commercial facility for cell and gene therapy manufacturing at its campus on Corbeil-Essonnes, France.

Yposkesi Launches Project SKY for its Second Commercial Bioproduction Site

The CGT Catapult has formed a consortium aimed at advancing the technology development and lowering costs of cell and gene therapy manufacturing.

CGT Catapult Forms Consortium to Accelerate Manufacturing Technology Development

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

VIVEbiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapies

The Discovery Labs has signed a foundational lease with the University of Pennsylvania Gene Therapy Program to build a new life sciences cluster in King of Prussia, Pa.

The Discovery Labs Secures Pennsylvania Location for New Life Sciences Cluster

Biogen and Ginkgo Bioworks have partnered to develop a next-generation AAV production platform to accelerate Biogen’s gene therapy drug development efforts.

Biogen and Ginkgo Bioworks in $120-Million Deal to Develop Novel Gene Therapy Manufacturing Platform

The Committee for Medicinal Products for Human Use of the European Medicines Agency presented a positive opinion of bluebird bio’s SKYSONA (elivaldogene autotemcel, Lenti-D), a one-time gene therapy for the treatment of early cerebral adrenoleukodystrophy, an X-linked metabolic disorder.

bluebird bio’s One-Time Gene Therapy for CALD Receives Positive Opinion from CHMP

Univercells will introduce the intermediate capacity scale-X carbo system to NIBRT’s facility for hands-on demonstration and training in CGT.

Univercells and NIBRT Team Up to Address Needs for Cell and Gene Therapy Training 

VectorY, a Netherlands-based biotechnology company, has been selected as the European winner of MilliporeSigma’s 2021 Advance Biotech Grant Program. 

MilliporeSigma Announces European Winner of its 2021 Advance Biotech Grant Program

Charles River plans to enhance its gene therapy capabilities through the acquisition of Vigene Biosciences. 

Manufacturing, Gene Therapies